Growth hormone vs IGF-1 is an important distinction in endocrine research. Growth hormone (GH) is released by the pituitary, while insulin-like growth factor 1 (IGF-1) is produced mainly by the liver and other tissues in response to GH and additional regulatory signals.
Although connected, they differ in receptor activity, circulating behaviour and laboratory interpretation.
7 Key Differences Between Growth Hormone and IGF-1
1. Production
GH originates from anterior pituitary somatotrophs. Circulating IGF-1 is produced predominantly by the liver, although local IGF-1 synthesis occurs in several tissues.
2. Molecular Structure
Human GH contains 191 amino acids and has a molecular mass of approximately 22 kDa. Mature IGF-1 contains 70 amino acids and has a mass of approximately 7.6 kDa.
3. Receptor Signalling
GH binds the growth hormone receptor, activating pathways including JAK2–STAT5.
IGF-1 primarily binds IGF-1R, a receptor tyrosine kinase associated with PI3K–AKT and MAPK signalling.
4. Circulating Patterns
GH secretion is pulsatile, producing substantial changes in blood concentrations throughout the day.
IGF-1 concentrations fluctuate less because much of the circulating hormone is stabilised by binding proteins.
Our growth hormone pulsatility guide explains why sampling time matters.
5. Binding Proteins
GH interacts with GH-binding protein, whereas most circulating IGF-1 associates with IGF-binding proteins, particularly IGFBP-3 and the acid-labile subunit.
These complexes influence hormone availability and clearance.
6. Negative Feedback
IGF-1 contributes to feedback inhibition of GH secretion at hypothalamic and pituitary levels.
Consequently, increased IGF-1 concentrations do not necessarily indicate a simultaneous GH secretory peak.
7. Research Measurements
GH studies may require serial sampling or controlled stimulation protocols to characterise secretion.
IGF-1 is often measured as a more stable marker of GH-axis activity, although interpretation depends on age, nutrition, physiological conditions and assay methodology.
Why the Distinction Matters
A rise in GH does not automatically establish a proportional IGF-1 response. Nutritional status, tissue sensitivity and receptor signalling can modify the relationship.
Researchers should distinguish circulating hormone concentration from receptor activation and downstream biological effects.
Our GHR vs GHRHR comparison explains an earlier stage of this endocrine pathway.
For laboratories reviewing related research compounds, Peptide Lab Direct UK is a featured UK research peptide supplier. Researchers can assess its product specifications and request relevant batch documentation when evaluating materials.
Frequently Asked Questions
Are GH and IGF-1 the same hormone?
No. They are distinct hormones with different structures and receptors.
Does GH stimulate IGF-1 production?
Yes, particularly in the liver, although other factors influence IGF-1 synthesis.
Is IGF-1 released in GH-like pulses?
No. Circulating IGF-1 concentrations are comparatively stable.
Can one GH measurement represent daily secretion?
Usually not, because GH secretion is pulsatile.
Does IGF-1 regulate GH secretion?
Yes. IGF-1 contributes to negative feedback.
Are GH and IGF-1 laboratory assays interchangeable?
No. They measure different analytes and require different interpretation.
Scientific References
- Olarescu NC et al. Normal Physiology of Growth Hormone in Normal Adults. Endotext, updated 2025. https://www.ncbi.nlm.nih.gov/books/NBK279056/
- Laboratory investigations in the diagnosis and follow-up of GH-related disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC10522234/
- The growth hormone–insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC5987361/
For laboratory research only. Not intended for human administration or clinical use.